- FDA panel votes against broad rollout of Pfizer booster shot, endorses narrower usePOLITICO
- FDA panel votes for Pfizer’s booster shot for ages 65+Yahoo Finance
- Opinion | The U.S. Needs to Stop the Confusion Over Covid Vaccine BoostersThe New York Times
- 3 Things You Need to Know, 1 You Don’t: September 17thWFSB 3
- FDA panel endorses Pfizer’s COVID-19 vaccine booster for people 65 and older, high-risk patientsFox News
- View Full Coverage on Google News